3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
65
Other hematologic neoplasm
5
Classical hematology
5
Breast
5
Gynecologic
4
Gastrointestinal
4
Other
3
Genitourinary
3
Lymphoid
2
Head & Neck
2
Thoracic
1
Sarcoma
1
Plasma cell
1
NET
1
Myeloid
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Sarcoma
11
Osteosarcoma
4
Gastrointestinal Stromal Tumors
3
Gastrointestinal Neoplasms
3
Central Nervous System Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Oligodendroglioma
2
Meningioma
2
Melanoma
2
Medulloblastoma
2
Lymphoma
2
Hemangiosarcoma
2
Gliosarcoma
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Brain Neoplasms
2
Bone Neoplasms
2
Astrocytoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Radiation Injuries
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Plexosarcoma
1
Pituitary Neoplasms
1
Interventions
Cyclophosphamide
17
pembrolizumab
12
Doxorubicin
10
fludarabine
7
Irinotecan
7
Blood Specimen Collection
7
Temozolomide
6
Gemcitabine
6
Etoposide
6
Radiotherapy
5
Ifosfamide
5
Carboplatin
5
Albumin-Bound Paclitaxel
5
tecogalan
4
cemiplimab
4
Vincristine
4
Trabectedin
4
Paclitaxel
4
Nivolumab
4
Filgrastim
4
Drug Therapy
4
Dexamethasone
4
Bevacizumab
4
pazopanib
3
olaparib
3
nilotinib
3
dostarlimab
3
aflibercept
3
Therapeutics
3
Taxes
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Surveys and Questionnaires
×
Sarcoma
×
Clear all
NCT06535997
2025-08-06
PRIMHADRON
Hospices Civils de Lyon
Completed
62 enrolled